KATHRYN COLE
Profile
First Name
: KATHRYN
Middle Name
:
Last Name
: COLE
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
RUSSELL CLAYTON, D.O., JOHN C. COOPER, JOHN G. COOPER, GEORGE COX, CRAIG FRASER, CRAIG E. FRASER, DANIEL GEFFKEN, THOMAS C. HOY, JAMES HUANG, JOHN LEONE, JOHN R. LEONE, MICHAEL L. MAGEE, JOSEPH MAHADY, JOSEPH M. MAHADY, THOMAS F. MILLER, PH.D., MBA, BRUCE PEACOCK, BRUCE A. PEACOCK, MARVIN E. ROSENTHALE, MARVIN E. ROSENTHALE, PH.D., BRIAN SCHREIBER, STEVEN SIMONSON, STEVEN A. SIMONSON, JOHN TATTORY, JOHN A. TATTORY, MARY B. TEMPLETON, MARY B. TEMPLETON, ESQ., LAWRENCE A. WEINSTEIN
EXECUTIVE OFFICER
RUSSELL CLAYTON, D.O., JOHN C. COOPER, JOHN G. COOPER, GEORGE COX, CRAIG FRASER, CRAIG E. FRASER, DANIEL GEFFKEN, THOMAS C. HOY, JAMES HUANG, JOHN LEONE, JOHN R. LEONE, MICHAEL L. MAGEE, JOSEPH MAHADY, JOSEPH M. MAHADY, THOMAS F. MILLER, PH.D., MBA, BRUCE PEACOCK, BRUCE A. PEACOCK, MARVIN E. ROSENTHALE, MARVIN E. ROSENTHALE, PH.D., BRIAN SCHREIBER, STEVEN SIMONSON, STEVEN A. SIMONSON, JOHN TATTORY, JOHN A. TATTORY, MARY B. TEMPLETON, MARY B. TEMPLETON, ESQ., LAWRENCE A. WEINSTEIN
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2018-12-21
D/A
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1,000,001 - $5,000,000
Equity
2018-03-30
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1,000,001 - $5,000,000
2018-07-02
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1,000,001 - $5,000,000
Equity
2018-03-30
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1,000,001 - $5,000,000
Equity
2017-10-27
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1,000,001 - $5,000,000
Equity
2017-02-13
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1 - $1,000,000
2014-10-10
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1 - $1,000,000
2013-12-03
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
NO REVENUES
Equity
2013-08-31
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
NO REVENUES
Equity
2013-05-24
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
NO REVENUES
Equity
2013-02-28
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
NO REVENUES
2013-02-13
